These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31699316)

  • 21. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of TDP-43 in Alzheimer's Disease.
    Chang XL; Tan MS; Tan L; Yu JT
    Mol Neurobiol; 2016 Jul; 53(5):3349-3359. PubMed ID: 26081142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.
    Lin L; Zheng LJ; Zhang LJ
    Mol Neurobiol; 2018 Nov; 55(11):8243-8250. PubMed ID: 29524051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy and Alzheimer's Disease.
    Li Q; Liu Y; Sun M
    Cell Mol Neurobiol; 2017 Apr; 37(3):377-388. PubMed ID: 27260250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?
    Praticò D; Trojanowski JQ
    Neurobiol Aging; 2000; 21(3):441-5; discussion 451-3. PubMed ID: 10858591
    [No Abstract]   [Full Text] [Related]  

  • 26. Current viral-mediated gene transfer research for treatment of Alzheimer's disease.
    Sasmita AO
    Biotechnol Genet Eng Rev; 2019 Apr; 35(1):26-45. PubMed ID: 30317930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.
    Serý O; Povová J; Míšek I; Pešák L; Janout V
    Folia Neuropathol; 2013; 51(1):1-9. PubMed ID: 23553131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAPK1: a Novel Pathology and Treatment Target for Alzheimer's Disease.
    Xu LZ; Li BQ; Jia JP
    Mol Neurobiol; 2019 Apr; 56(4):2838-2844. PubMed ID: 30062675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
    Obulesu M; Rao DM
    Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: clinical molecular and genetic studies on Alzheimer's disease.
    Shoji M
    J Pharmacol Sci; 2012; 118(3):345-9. PubMed ID: 22382661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.
    Rosini M; Simoni E; Caporaso R; Minarini A
    Future Med Chem; 2016 Apr; 8(6):697-711. PubMed ID: 27079260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease.
    Skelton JB
    J Am Pharm Assoc (2003); 2008; 48(6):715-21. PubMed ID: 19019799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
    Jia L; Piña-Crespo J; Li Y
    Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cdk5 in Alzheimer's Disease.
    Liu SL; Wang C; Jiang T; Tan L; Xing A; Yu JT
    Mol Neurobiol; 2016 Sep; 53(7):4328-42. PubMed ID: 26227906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretases as targets for the treatment of Alzheimer's disease.
    Citron M
    Mol Med Today; 2000 Oct; 6(10):392-7. PubMed ID: 11006528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detangling Alzheimer's disease.
    Helmuth L
    Sci Aging Knowledge Environ; 2001 Oct; 2001(1):oa2. PubMed ID: 14602946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management].
    Zhang H; Zheng Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):702-708. PubMed ID: 31699204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.